Effects of hyperbaric and hyperoxic conditions on the disposition of drugs: Theoretical considerations and a review of the literature

General Pharmacology

Volumn 32, Issue 1, 1999, Pages 127-133

  Rump, A F E ^a   Siekmann, U ^a   Kalff, G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Diving; Drugs; Hyperbaric oxygenation; Hyperoxia; Pharmacokinetics; Pharmacology

Indexed keywords

AMINOPHENAZONE; ANILINE; CAFFEINE; DIAZEPAM; FENTANYL; FLUNITRAZEPAM; GENTAMICIN; LIDOCAINE; METHOHEXITAL; MIDAZOLAM; NIFEDIPINE; PENTOBARBITAL; PETHIDINE; PROMETHAZINE; SALICYLIC ACID; THEOPHYLLINE; THIOPENTAL; VERAPAMIL;

CLINICAL TRIAL; DECOMPRESSION SICKNESS; DIVING; DOG; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG METABOLISM; HUMAN; HYPERBARISM; HYPEROXIA; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; REVIEW; VOLUNTEER;

ANIMALS; ANOXIA; DECOMPRESSION SICKNESS; DOGS; HUMANS; HYPERBARIC OXYGENATION; KIDNEY; LIVER; PHARMACOKINETICS; RATS;

EID: 0032890135     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00074-3     Document Type: Review

References (45)

1. Ananian A.A., Miliutina W.P., Shugalei V.S., Sherstner K.B., Kostkin V.B. The cytochrome P-450 content and catalytic activity in rat liver microsomes during hyperbaric oxygenation. Biol. Nauki. 12:1991;28-33.
2. Arthur D.C., Margulies R.A. A short course in diving medicine. Ann. Emerg. Med. 16:1987;689-701.
3. Bennett P.B. Inert gas narcosis. Bennett P.B., Elliott D.H. The Physiology and Medicine of Diving. 1993;170-193 Saunders, London, Philadelphia, Toronto, Sydney, Tokyo.
4. Blyden G., Silverstein F., Epstein M., Norsk P., Brenner B., Nwadike N., Dorvil M. Lidocaine pharmacokinetics during water immersion in normal humans. J. Appl. Physiol. 66:1989;57-60.
5. Boehm F., Almeling M. Ueberlegungen zum Einsatz von Acetylsalicylsäure beim Tauchunfall. Notarzt. 11:1995;9-12.
6. Bonate P.L. Pathophysiology and pharmacokinetics following burn injury. Clin. Pharmacokinet. 18(2):1990;118-130.
7. Bove A.A. The basis for drug therapy in decompression sickness. Undersea Biomed. Res. 9:1982;91-111.
8. Buech H.P., Buech U. Hypnotika. pharmakotherapie bei Schlafstörungen und Errengungszuständen Forth W., Henschler D., Rummel W., Starke K. Allgemeine und Spezielle Pharmakologie und Toxikologie. 1992;254-263 BI-Wissenschaftsverlag, Mannheim, Leipzig, Wien, Zürich.
9. Buehlmann A.A. Tauchmedizin. 1993;Springer-Verlag, Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest.
10. Christie J., Markowsky S.J., Valdes C. Acute trauma alters morphine clearance. J. Trauma. 39:1995;749-752.
11. Clark J.M. Oxygen toxicity. Bennett P.B., Elliott D.H. The Physiology and Medicine of Diving. 1993;121-169 Saunders, London, Philadelphia, Toronto, Sydney, Tokyo.
12. Davis L.E., Westfall B.A. Species differences in biotransformation and excretion of salicylate. Am. J. Vet. Res. 33:1972;1253-1262.
13. Edmonds C., Lowry C., Pennefather J. Diving and Subaquatic Medicine. 1992;Butterworth Heinemann, Oxford, London, Boston, Munich, New Delhi, Singapore, Sydney, Tokyo, Toronto, Wellington.
14. Fischer B., Jain K.K., Braun E., Lehrl S. Handbook of Hyperbaric Oxygen Therapy. 1988;Springer-Verlag, Berlin, Heidelberg, New York, London, Paris, Tokyo.
15. Gleiter C.H., Deckert J. Coffein. Klinische Pharmakologie und Anwendung als Pharmakon Arzneimitteltherapie. 10(8):1992;244-255.
16. Gooden B.A. Mechanism of the human diving response. Integr. Physiol. Behav. Sci. 29:1994;6-16.
17. Greenleaf J.E., Shvartz E., Kravik S., Keil L.C. Fluid shifts and endocrine responses during chair rest and water immersion in man. J. Appl. Physiol. 48:1980;79-88.
18. Gross D.R., Kramer W.G., Gentile B.J., Welch D.W., Fife W.P. Plasma volume and estimated liver plasma flow during hyperbaric and hyperoxic exposures in awake dogs. Aviat. Space Environ. Med. 56:1985;1203-1208.
19. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 1989;Clarendon Press, Oxford.
20. Harrison L.J. Drugs and diving. J. Florida MA. 79:1992;165-167.
21. Hordnes C., Tyssebotn I. Effect of high ambient pressure and oxygen tension on organ blood flow in conscious trained rats. Undersea Biomed. Res. 12:1985;115-128.
22. Hull C.J. Pharmacokinetics for Anaesthesia. 1991;Butterworth Heinemann, Oxford, London, Boston, Munich, New Delhi, Singapore, Tokyo, Toronto, Wellington.
23. Jurna I. Analgetika. Schmerzbekämpfung Forth W., Henschler D., Rummel W., Starke K. Allgemeine und Spezielle Pharmacologie und Toxikologie. 1992;200-224 BI-Wissenschaftsverlag, Mannheim, Leipzig, Wien, Zürich.
24. Kent T.A., Sheftel T.G., Sutton T.E., Morrison L.T., Mader J.T. Effect of hyperbaric oxygen on the blood cerebrospinal fluid transfer of tobramycin. Aviat. Space Environ. Med. 57:1986;664-666.
25. Knobeldorff V.G. Druckluft-und Tauchunfälle im Rettungsdienst. Notarzt. 9:1993;142-146.
26. Koska A.J. III, Kramer W.G., Romagnoli A., Keats A.S., Sabawala P.B. Pharmacokinetics of high dose meperidine in surgical patients. Anesth. Analg. 60:1981;8-11.
27. Kramer W.G., Gross D.R., Fife W.P., Chaikin B.N. Theophylline pharmacokinetics during hyperbaria and hyperbaric hyperoxia in the dog. Res. Commun. Chem. Pathol. Pharmac. 34:1981;381-388.
28. Kramer W.G., Welch D.W., Fife W.P., Chaikin B.N., Medlock C., Gross D.R. Pharmacokinetics of pentobarbital under hyperbaric and hyperbaric hyperoxic conditions in the dog. Aviat. Space Environ. Med. 54:1983;1005-1008. a.
29. Kramer W.G., Gross D.R., Moreau P.M., Fife W.P. Drug disposition under hyperbaric and hyperbaric hyperoxic conditions. meperidine in the dog Aviat. Space Environ. Med. 54:1983;410-412. b.
30. Kramer W.G., Welch D.W., Fife W.P., Chaikin B.N., Gross D.R. Salicylate pharmacokinetics in the dog at 6 ata in air and at 2.8 ata in 100% oxygen. Aviat. Space Environ. Med. 54:1983;682-684. c.
31. Lange H., Bircher J. Pathophysiologische und pharmakologische Determinanten des hepatischen Arzneimittelstoffsechsels. Dennhardt R., Heinemeyer G., Gramm H.J. Aspekte der Arzneitherapie bei Intensivpatienten. 1988;29-37 Springer Verlag, Berlin, Heidelberg, New York, London, Paris, Tokyo.
32. Merritt G.J., Slade J.B. Influence of hyperbaric oxygen on the pharmacokinetics of single dose gentamicin in healthy volunteers. Pharmacotherapy. 13:1993;382-385.
33. Moon R.E., Gorman D.F. Treatment of the decompression disorders. Bennett P.B., Elliott D.H., Saunders London, Philadelphia Toronto, Sydney Tokyo The Physiology and Medicine of Diving. 1993.
34. Neugebauer E., Dietrich A., Lechleuthner A., Bouillon B., Eypasch E. Pharmacotherapy in shock syndromes. the neglected field of pharmacokinetics and pharmacodynamics Cir. Shock. 36:1992;312-320.
35. Pincemail J., Defraigne J.O., Limet R. Oxidative stress in clinical situations. fact or fiction? Eur. J. Anaesthesiol. 13:1996;219-234.
36. Risberg J., Bergo G.W., Hordnes C., Tyssebotn I. Distribution of cardiac output in awake rats during exposure to 5 bar. Undersea Biomed. Res. 17:1990;503-514.
37. Risberg J., Hordnes C., Stuhr L.E.B., Tyssebotn I. Effect of β1-adrenoceptor blockade in rats at 5 bar ambient pressure. Undersea Hyper. Med. 21:1994;371-385.
38. Rump A.F.E., Klaus W. Evidence for norepinephrine cardiotoxicity mediated by superoxide anion radicals in isolated rabbit hearts. Naunyn-Schmiedeberg's Arch. Pharmac. 349:1994;295-300.
39. Rump A.F.E., Rosen R., Klaus W. Cardioprotection by superoxide dismutase. a catecholamine-dependent process? Anesth. Analg. 76:1993;239-246.
40. Rump A.F.E., Siekmann U., Dreja M., Kalff G. Caffeine pharmacokinetics during hyperbaric hyperoxia in humans. Aviat. Space Environ. Med. 68:1997;142-146.
41. Schaeffer D.O., Caprile K.A., Strain G.M., Bivin W.S., Cohn G.H. Effect of hyperbaric oxygen on cerebrospinal fluid gentamicin concentrations. J. Vet. Pharmac. Ther. 15:1992;104-106.
42. Sledkov A.I., Troshikhin G.V. Duration of the narcotic action of nembutal under hyperbarism. Farmakol. Toksikol. 49:1986;32-35.
43. Stegemann J. Leistungsphysiologie. 1991;Thieme Verlag, Stuttgart, New York.
44. Theisohn M., Biederbick W., Rump A.F.E. Therapeutisches Arzneimittelmonitoring (TDM). Hummerich W., Keller R., Schrappe M. Klinischer Leitfaden durch das Labor. 1997;415-434 Biermann Verlag, Zuelpich.
45. Zito R.A., Reid P.R. Lidocaine kinetics predicted by indocyanine green clearance. N. Engl. J. Med. 298:1978;1160-1163.